Read More 1 minute read Funding News News Pharmaceutical Blackstone Partners with Moderna on $750M Flu Program Investment Key Highlights Blackstone Life Sciences commits up to $750 million to fund Moderna’s influenza vaccine program. The partnership highlights a… byChris-Anne RoqueApril 2, 2024